Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically...

por Alomran, Nessrin, Alsolaiss, Jaffer, Albulescu, Laura-Oana, Crittenden, Edouard, Harrison, Robert A., Ainsworth, Stuart, Casewell, Nicholas R.
Publicado 2021

Correction: Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of ge...

por Alomran, Nessrin, Alsolaiss, Jaffer, Albulescu, Laura-Oana, Crittenden, Edouard, Harrison, Robert A., Ainsworth, Stuart, Casewell, Nicholas R.
Publicado 2022

A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite

por Albulescu, Laura-Oana, Xie, Chunfang, Ainsworth, Stuart, Alsolaiss, Jaffer, Crittenden, Edouard, Dawson, Charlotte A., Softley, Rowan, Bartlett, Keirah E., Harrison, Robert A., Kool, Jeroen, Casewell, Nicholas R.
Publicado 2020

Author Correction: A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite

por Albulescu, Laura-Oana, Xie, Chunfang, Ainsworth, Stuart, Alsolaiss, Jaffer, Crittenden, Edouard, Dawson, Charlotte A., Softley, Rowan, Bartlett, Keirah E., Harrison, Robert A., Kool, Jeroen, Casewell, Nicholas R.
Publicado 2021

Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition

por Menzies, Stefanie K., Dawson, Charlotte A., Crittenden, Edouard, Edge, Rebecca J., Hall, Steven R., Alsolaiss, Jaffer, Wilkinson, Mark C., Casewell, Nicholas R., Harrison, Robert A., Ainsworth, Stuart
Publicado 2022

In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus

por Menzies, Stefanie K., Clare, Rachel H., Xie, Chunfang, Westhorpe, Adam, Hall, Steven R., Edge, Rebecca J., Alsolaiss, Jaffer, Crittenden, Edouard, Marriott, Amy E., Harrison, Robert A., Kool, Jeroen, Casewell, Nicholas R.
Publicado 2022

Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms

por Alomran, Nessrin, Blundell, Patricia, Alsolaiss, Jaffer, Crittenden, Edouard, Ainsworth, Stuart, Dawson, Charlotte A., Edge, Rebecca J., Hall, Steven R., Harrison, Robert A., Wilkinson, Mark C., Menzies, Stefanie K., Casewell, Nicholas R.
Publicado 2022

Two snakebite antivenoms have potential to reduce Eswatini’s dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing

por Menzies, Stefanie K., Litschka-Koen, Thea, Edge, Rebecca J., Alsolaiss, Jaffer, Crittenden, Edouard, Hall, Steven R., Westhorpe, Adam, Thomas, Brent, Murray, James, Shongwe, Nondusimo, Padidar, Sara, Lalloo, David G., Casewell, Nicholas R., Pons, Jonathan, Harrison, Robert A.
Publicado 2022